Form 4: Oracle Vice Chairman Jeffrey Henley Reports Stock Transactions
SEC Form 4
Jeffrey Henley, Vice Chairman of Oracle, reports the vesting and disposal of restricted stock units and associated tax withholdings.
Summary
- Jeffrey Henley, Vice Chairman of Oracle, filed a Form 4 detailing changes in his beneficial ownership of Oracle stock on August 5, 2024.
- The transactions include the vesting of 25,000 restricted stock units (RSUs) twice, each convertible to common stock.
- Henley also disposed of 10,991 and 10,990 shares of common stock, respectively, to cover tax liabilities associated with the vesting of the RSUs, at a price of $133.28 per share.
- Following these transactions, Henley directly owns 25,000 restricted stock units and indirectly owns 1,135,935 shares through a trust and 706,214 shares through a GRAT.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting standard compensation practices. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transactions have a minor dilutive effect on existing shareholders due to the vesting of new shares, offset by the shares sold for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/20/19 | Power of Attorney Filed |
| 08/05/2024 | Date of earliest transaction: Vesting of restricted stock units and stock disposal for tax liability |
| 08/07/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.